Lastly, the regulatory elements of lncRNAs that are highly expressed in cancers may be harnessed for therapeutic approaches as in the case of BC-819, the vector driving expression of the diphtheria toxin A from the H19 promoter, which is in clinical trials and may be applicable to HPV16 positive tumors as well (see Section 4.5). Here, H19 is linked to breast cancer.